ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,706Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 181

$804K Total Retail Price of All Prescriptions

Rank: 5 out of 181

523 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 523 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

8% of this provider’s 523 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 12,124 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 43%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $106 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 669 501 1 3
LEVOTHYROXINE SODIUM 587 504 2 1
OMEPRAZOLE 543 394 3 14
LISINOPRIL 522 441 4 5
FUROSEMIDE 456 374 5 18
TRAZODONE HCL 453 379 6 37
WARFARIN SODIUM 399 357 7 28
AMLODIPINE BESYLATE 391 353 8 11
ATENOLOL 377 303 9 17
CITALOPRAM HBR 369 300 10 36
METFORMIN HCL 351 257 11 2
METOPROLOL TARTRATE 315 265 12 22
MIRTAZAPINE 313 300 13 65
GABAPENTIN 294 199 14 31
HYDROCHLOROTHIAZIDE 283 240 15 16
METOPROLOL SUCCINATE 241 211 16 32
HYDROCODONE-ACETAMINOPHEN 212 128 S3 17 42
TRAMADOL HCL 183 165 18 43
QUETIAPINE FUMARATE 178 154 19 107
POTASSIUM CHLORIDE 166 146 20 69
DONEPEZIL HCL 150 150 21 70
RANITIDINE HCL 149 124 22 62
LANTUS 145 96 23 6
GLIPIZIDE 145 126 23 23
NAMENDA 142 142 25 72
OXYCODONE-ACETAMINOPHEN 140 45 S2 26 54
ALENDRONATE SODIUM 130 110 27 20
SERTRALINE HCL 127 94 28 48
ZOLPIDEM TARTRATE 126 71 29 57
ATORVASTATIN CALCIUM 124 96 30 19
PRAVASTATIN SODIUM 123 115 31 26
DIVALPROEX SODIUM 119 114 32 94
PREDNISONE 118 63 33 53
LACTULOSE 111 106 34 109
TAMSULOSIN HCL 102 95 35 64
OLANZAPINE 101 73 36 102
ALLOPURINOL 99 74 37 45
RISPERIDONE 98 96 38 135
CYMBALTA 94 46 39 113
PANTOPRAZOLE SODIUM 90 68 40 51
NOVOLIN N 89 65 41 59
PROAIR HFA 88 48 42 52
NOVOLIN R 85 57 43 139
SEROQUEL 84 68 44 140
SPIRONOLACTONE 84 59 44 68
PAROXETINE HCL 83 68 46 87
LEVETIRACETAM 83 52 46 143
FLUTICASONE PROPIONATE 82 49 48 67
DIGOXIN 76 73 49 82
CRESTOR 73 52 50 35
CLOPIDOGREL 73 66 50 77
ADVAIR DISKUS 72 39 52 83
BUSPIRONE HCL 69 39 53 149
SPIRIVA 66 47 54 154
PHENYTOIN SODIUM EXTENDED 65 45 55 155
CLONIDINE HCL 63 51 56 106
LOSARTAN POTASSIUM 62 60 57 30
FLUOXETINE HCL 62 40 57 76
METHADONE HCL 60 26 S2 59 161
DOXYCYCLINE HYCLATE 57 31 60 165
FINASTERIDE 57 45 60 128
DETROL LA 56 56 62 168
LOVASTATIN 54 50 63 46
DOXAZOSIN MESYLATE 52 52 64 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.